R-nuucell, one of our spin-offs, focuses on the development of new anticancer chemotherapeutics to treat metastatic cancer and was part of the group of 20 startups that presented themselves to investors at CUF Tejo, in Lisbon.
Cuf Tejo (left); Cornelius Schmaltz Head of Unit EIC Accelerator (center); Paula Brito Silva Executive Board Member at CUF (right).
At the EIC x CUF Investor Day on Healthcare, 20 startups financed by the European Innovation Council (EIC) had the opportunity to present their work to 20 international investors in the health sector, by doing three thematic pitching sessions. Besides this, the program included a plethora of networking activities among the participants.
Cornelius Schmaltz Head of Unit EIC Accelerator engaging with the participants.
The “Health Investor Day” was promoted by the European Innovation Council, the main innovation program in Europe to identify, develop, and expand revolutionary technologies and innovations – in partnership with CUF – a healthcare provider and had with the objective of bringing together investors and startups, promoting networking and potential funding for innovative projects in the health area.
You can know more about this event here.
